Clinical Trials Logo

Clinical Trial Summary

The aim of this study is to investigate the effect of addition of intranasal ketamine to midazolam compared to midazolam alone as a premedication on the occurrence of PRAEs


Clinical Trial Description

Perioperative respiratory adverse events (PRAEs) are the most common complication during pediatric anesthesia furthermore, most children presenting for AT have sleep-disordered breathing and obstructive sleep apnea syndrome (OSAS) caused by tonsillar hypertrophy which could aggravate the PRAEs specially with the use of the conventional sedatives as a premedication. A recent randomized controlled trial has shown that more than 50% of children premedicated with midazolam had experienced PRAEs . Midazolam and ketamine are commonly used as preoperative sedative drugs for pediatric populations. Ketamine is a safe and widely used sedative and analgesic in the pediatric emergency department (ED) with less profound effects on the upper airway and respiratory muscles. Intranasal ketamine administration is well tolerated and without serious adverse effects. The addition of ketamine to midazolam as a preoperative sedation to reduce the occurrence of PRAEs was not investigated before in children undergoing AT. The authors hypothesize that combination of ketamine to midazolam could offer optimum sedation condition while reducing the occurrence of PRAEs in children undergoing AT. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06122948
Study type Interventional
Source Kasr El Aini Hospital
Contact Khaled Sarhan, MD
Phone +201020067816
Email khaled.sarhan@kasralainy.edu.eg
Status Recruiting
Phase Phase 3
Start date September 10, 2023
Completion date September 1, 2024

See also
  Status Clinical Trial Phase
Completed NCT03266094 - A Study of BiZactâ„¢ on Children and Adolescents Undergoing Tonsillectomy N/A
Completed NCT02228135 - The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage N/A
Completed NCT00662987 - Effect of Duration of Antibiotic Therapy on Recovery Following Tonsillectomy N/A
Completed NCT00273754 - The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA). Phase 2
Recruiting NCT03783182 - Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy Phase 4
Completed NCT03793816 - Tonsillectomy Using BiZactâ„¢ - a Randomized Side-controlled Clinical Trial N/A
Not yet recruiting NCT06359925 - Suprazygomatic Nerve Block in Tonsillectomy Patients N/A
Recruiting NCT06079125 - PFDD Versus PFDRT in Chiari Decompression Surgery N/A
Recruiting NCT01904461 - HemORL: Monocentric, Prospective, Comparative Study on the Use of a Haemostatic Vacuum Device During Tonsillectomy in Children N/A
Not yet recruiting NCT00756873 - Etoricoxib in Ear Nose Throat Surgery Phase 3
Recruiting NCT05600595 - The Evaluation of Eustachian Tube Function and Its Influencing Factors After Snoring Operation in Children
Completed NCT02987985 - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy Phase 3
Completed NCT04066829 - Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy N/A
Recruiting NCT05158348 - A Comparative Study to Measure the Effect of Nebulized Dexmedetomidine Phase 3
Completed NCT01605903 - Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy Phase 2
Enrolling by invitation NCT02444533 - EXPAREL® for Pain After Tonsillectomy Phase 4
Recruiting NCT02829515 - Tonsil Surgery in Sweden: A National Quality Register
Not yet recruiting NCT03491085 - Role of Antibiotics Post Tonsillectomy Phase 1/Phase 2
Recruiting NCT05270109 - Cold Steel Versus "Hot" BiZact Tonsillectomy; Comparing Post Tonsillectomy Morbidity N/A
Recruiting NCT05161754 - Tonsillectomy and Risk of Post-Tonsillectomy Hemorrhage N/A